Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Aptevo Therapeutics Inc. (APVO) had Return on Equity of -507.47% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-24.13M |
|
-- |
|
-- |
|
$24.60M |
|
$-24.60M |
|
$0.47M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.60M |
|
$-24.25M |
|
0.01M |
|
0.01M |
|
$-1747.60 |
|
$-1747.60 |
|
| Balance Sheet Financials | |
$10.66M |
|
$0.54M |
|
$4.93M |
|
$15.59M |
|
$6.21M |
|
-- |
|
$4.63M |
|
$10.84M |
|
$4.75M |
|
$4.75M |
|
$4.75M |
|
0.07M |
|
| Cash Flow Statement Financials | |
$-23.79M |
|
-- |
|
$15.60M |
|
$16.90M |
|
$8.71M |
|
$-8.19M |
|
$1.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-507.47% |
-507.47% |
|
-154.77% |
|
-507.47% |
|
$63.48 |
|
$-1722.70 |
|
$-1722.70 |
|